Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bIAP for prevention of inflammatory complications after invasive cardiac surgery
2009-010191-19Phase 2Active
- Sponsor
- Alloksys Life Sciences
- Start
- Oct 2009
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Systemic Inflammatory Response Syndrome (SIRS) comparing bIAP with Placebo (2 arms). Primary endpoints: Reduction of post-surgical systemic inflammatory response syndrome and Pro-inflammatory cytokine levels. Started Oct 2009; status: active.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on 2009-010191-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010191-19.